Literature DB >> 21827889

Immune-mediated acquired ataxias.

Marios Hadjivassiliou1.   

Abstract

The cerebellum, and in particular the Purkinje cells within it, appear to be a frequent immunological target in the context of some systemic diseases. This is perhaps more often the case with the cerebellum by comparison to other structures within the central nervous system. This observation may relate to the fact that the cerebellum is one of the largest, oldest, and most structurally conserved structures in the vertebrate nervous system and/or that Purkinje cells possess good and multiple antigenic targets. Immune-mediated ataxias include paraneoplastic cerebellar degeneration and post-infective cerebellitis, but these will be discussed elsewhere. This chapter covers in detail the epidemiology, clinical characteristics, pathophysiology, and treatment of some other examples of immune-mediated ataxias, including gluten ataxia and ataxia associated with anti-GAD antibodies. There is particular emphasis on gluten ataxia as this is one of the commonest immune-mediated cerebellar ataxias and one of the few ataxias that are potentially treatable. The chapter also introduces the concept of primary autoimmune cerebellar ataxia as a form of organ-specific autoimmune disease for the first time. The pathophysiology leading to cerebellar damage, loss of Purkinje cells, and the development of ataxia remains speculative, but existing clues are discussed in detail. 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21827889     DOI: 10.1016/B978-0-444-51892-7.00011-5

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  12 in total

Review 1.  Advances in the Pathogenesis of Auto-antibody-Induced Cerebellar Synaptopathies.

Authors:  Hiroshi Mitoma; Mario Manto
Journal:  Cerebellum       Date:  2022-01-22       Impact factor: 3.847

2.  Alcohol induces sensitization to gluten in genetically susceptible individuals: a case control study.

Authors:  Stuart Currie; Nigel Hoggard; Matthew J R Clark; David S Sanders; Iain D Wilkinson; Paul D Griffiths; Marios Hadjivassiliou
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

3.  Proliferative response of peripheral blood mononuclear cells in anti-Hu antibody-associated patients with paraneoplastic neurological syndrome and their depressant effect on small cell lung cancer cells.

Authors:  Liang Yin; Hongdang Qu; Qiming Chen
Journal:  Mol Med Rep       Date:  2014-11-19       Impact factor: 2.952

4.  Alcohol-related cerebellar degeneration: not all down to toxicity?

Authors:  Priya D Shanmugarajah; Nigel Hoggard; Stuart Currie; Daniel P Aeschlimann; Pascale C Aeschlimann; Dermot C Gleeson; Mohammed Karajeh; Nicola Woodroofe; Richard A Grünewald; Marios Hadjivassiliou
Journal:  Cerebellum Ataxias       Date:  2016-10-03

5.  Time Is Cerebellum.

Authors:  Hiroshi Mitoma; Mario Manto; Christiane S Hampe
Journal:  Cerebellum       Date:  2018-08       Impact factor: 3.847

Review 6.  Immune-mediated cerebellar ataxias: from bench to bedside.

Authors:  Hiroshi Mitoma; Mario Manto; Christiane S Hampe
Journal:  Cerebellum Ataxias       Date:  2017-09-21

Review 7.  Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias.

Authors:  Hiroshi Mitoma; Jerome Honnorat; Kazuhiko Yamaguchi; Mario Manto
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

Review 8.  Recent Advances in the Treatment of Cerebellar Disorders.

Authors:  Hiroshi Mitoma; Mario Manto; Jordi Gandini
Journal:  Brain Sci       Date:  2019-12-23

Review 9.  Consensus Paper. Cerebellar Reserve: From Cerebellar Physiology to Cerebellar Disorders.

Authors:  H Mitoma; A Buffo; F Gelfo; X Guell; E Fucà; S Kakei; J Lee; M Manto; L Petrosini; A G Shaikh; J D Schmahmann
Journal:  Cerebellum       Date:  2020-02       Impact factor: 3.847

Review 10.  Cerebellar long-term depression and auto-immune target of auto-antibodies: the concept of LTDpathies.

Authors:  Hiroshi Mitoma; Jerome Honnorat; Kazuhiko Yamaguchi; Mario Manto
Journal:  Mol Biomed       Date:  2021-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.